Conclusions: This first longitudinal real-world US study indicates a positive trend in Hb, fatigue, and cognition with limited HCRU during pegcetacoplan treatment in adults with PNH. The gene discussed is GSTM1; the disease is paroxysmal nocturnal hemoglobinuria.